Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Acta Dermato-Venereologica, 2023
Serum Interleukin-13 and Caspase 8 are Elevated in Prurigo Nodularis

Ju T., Labib A., Nattkemper L. et al.

Olink Target 96Dermatological DiseasesPathophysiologyPatient StratificationSerum

Hepatology, 2023
Plasma proteomic signature of fatty liver disease: The Rotterdam Study

Abozaid Y., Ayada I., van Kleef L. et al.

Olink Target 96HepatologyPathophysiologyPatient StratificationPlasma

Molecular Psychiatry, 2023
Plasma proteins related to inflammatory diet predict future cognitive impairment

Duggan M., Butler L., Peng Z. et al.

Olink Target 96NeurologyNutritional ScienceAgingPathophysiologyPlasma

British Journal of Haematology, 2023
Plasma protein and venous thromboembolism: prospective cohort and mendelian randomisation analyses

Yuan S., Titova O., Zhang K. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Vaccines, 2023
Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen

Martinson N., Gordhan B., Petkov S. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasmaNasal Mucus Swabs

Science Translational Medicine, 2023
Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis

Biesemann N., Margerie D., Asbrand C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationCell Culture Supernatant

Cell Reports Medicine, 2023
Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer

Tang Z., Gu Y., Shi Z. et al.

Olink Target 96OncologyPatient StratificationSerum

Journal of Clinical Investigation, 2023
Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma

Huuhtanen J., Kasanen H., Peltola K. et al.

Olink Target 96OncologyImmunotherapyPathophysiologySerum

Journal of Virology, 2023
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction

Duran-Castells C., Llano A., Kawana-Tachikawa A. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasmaCSF

Biomarker Research, 2023
Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1

Campbell K., Cawley N., Luke R. et al.

Olink Explore 3072/384NeurologyPatient StratificationCSF

Immunity & Ageing, 2023
Mitochondrial DNA and inflammatory proteins are higher in extracellular vesicles from frail individuals

Byappanahalli A., Noren Hooten N., Vannoy M. et al.

Olink Target 96AgingPathophysiologyEV Lysate

Clinical Chemistry and Laboratory Medicine (CCLM), 2023
Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood

Andreasson U., Gobom J., Delatour V. et al.

Olink Target 96NeurologyTechnical EvaluationPlasmaSerum

JID Innovations, 2023
Modulation of Inflammatory Proteins in Serum May Reflect Cutaneous Immune Responses in Cancer Immunotherapy

Han J., Correa da Rosa J., Agarwal A. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationSerumTissue Lysate

Blood, 2023
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Penter L., Liu Y., Wolff J. et al.

OncologyImmunotherapyPathophysiologySerum

PLOS ONE, 2023
Proteomics biomarker discovery for individualized prevention of familial pancreatic cancer using statistical learning

Ha C., Müller-Nurasyid M., Petrera A. et al.

Olink Target 96OncologyData ScienceSerum

Translational Neurodegeneration, 2023
Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Yulug B., Altay O., Li X. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Molecular Medicine, 2023
Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS

Batra R., Uni R., Akchurin O. et al.

Olink Target 96Respiratory DiseasesInfectious DiseasesPathophysiologyPatient StratificationUrine

Journal of the American Heart Association, 2023
High Plasma Levels of Soluble Lectin‐like Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity

Stinson S., Jonsson A., Andersen M. et al.

Olink Target 96Metabolic DiseasesCVDPatient StratificationPlasma

Clinical Proteomics, 2023
Are the results from a multiplex proteomic assay and a conventional immunoassay for NT-proBNP and GDF-15 comparable?

Skau E., Wagner P., Leppert J. et al.

Olink Target 96CVDTechnical EvaluationPlasma

European Journal of Preventive Cardiology, 2023
Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction

Valdes-Marquez E., Clarke R., Hill M. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

2821 publications